NO20084987L - Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel - Google Patents

Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel

Info

Publication number
NO20084987L
NO20084987L NO20084987A NO20084987A NO20084987L NO 20084987 L NO20084987 L NO 20084987L NO 20084987 A NO20084987 A NO 20084987A NO 20084987 A NO20084987 A NO 20084987A NO 20084987 L NO20084987 L NO 20084987L
Authority
NO
Norway
Prior art keywords
nicotine
trometamol
pharmaceutical product
buffering agent
delivery
Prior art date
Application number
NO20084987A
Other languages
English (en)
Inventor
Per Steen
Darek Dymitrowics
Asa Waltermo
Roland Olsson
Katarina Lindell
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38694149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084987(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ab filed Critical Mcneil Ab
Publication of NO20084987L publication Critical patent/NO20084987L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Belagte orale doseringsformer for levering av nikotin i en hvilken som helst form til et subjekt ved rask intraoral levering av nikotin som innbefatter minst en kjerne, nikotin i en hvilken som helst form og/eller et nikotinetterlignende middel, minst ett belegglag og eventuelt minst ett eller flere andre additiver, hvori minst det ene belegglaget er bufret, hvorved det anvendes minst trometamol som buffer. Også omfattet er en fremgangsmåte for levering av nikotin i en hvilken som helst form, en fremgangsmåte for å redusere trangen til å røyke eller anvende tobakk så vel som en fremgangsmåte for å fremstille nevnte belagte produkt og anvendelsen av samme for å oppnå et raskt intraoralt opptak av nikotin.
NO20084987A 2006-05-16 2008-11-27 Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel NO20084987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0601090 2006-05-16
PCT/SE2007/000365 WO2007133141A1 (en) 2006-05-16 2007-04-18 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent

Publications (1)

Publication Number Publication Date
NO20084987L true NO20084987L (no) 2009-02-16

Family

ID=38694149

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084987A NO20084987L (no) 2006-05-16 2008-11-27 Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel

Country Status (16)

Country Link
US (1) US20070269492A1 (no)
EP (1) EP2023928A4 (no)
JP (1) JP5254213B2 (no)
KR (1) KR101414063B1 (no)
CN (1) CN101472591A (no)
AR (1) AR060931A1 (no)
AU (1) AU2007250589B2 (no)
BR (1) BRPI0712068A2 (no)
CA (1) CA2652500C (no)
MX (1) MX2008014726A (no)
NO (1) NO20084987L (no)
NZ (1) NZ572758A (no)
RU (1) RU2448707C2 (no)
TW (1) TW200810755A (no)
WO (1) WO2007133141A1 (no)
ZA (1) ZA200810618B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
ES2521494T3 (es) 2007-04-02 2014-11-12 Parkinson's Institute Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
GB2468424B (en) * 2007-04-02 2011-11-09 Parkinson S Inst Methods and compositions for reduction of side effects of therapeutic treatments
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
CL2009001025A1 (es) * 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
AU2013219211B2 (en) * 2008-05-01 2016-05-12 North Star OpCo Limited Nicotine lozenge compositions
SI2177213T1 (sl) * 2008-09-17 2013-03-29 Siegfried Ltd. Nikotin vsebujoč granulat
AU2009303979A1 (en) 2008-10-14 2010-04-22 Mcneil Ab Multi portion intra-oral dosage form and use thereof
EP2392331A1 (en) 2008-12-19 2011-12-07 Siegfried Ltd. Nicotine-containing product
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
DK2442668T3 (en) * 2009-06-19 2016-12-12 Fertin Pharma As Buffered RUBBER BASE FOR HIGH PH RELEASE
MX2012009586A (es) * 2010-02-18 2012-09-12 Jatin Vasant Thakkar Patillas de gelatina blanda con nicotina.
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
FR2993778B1 (fr) * 2012-07-30 2016-06-17 Pf Medicament Pastilles a cinetiques multiples de liberation de principes actifs
CN102926277B (zh) * 2012-11-14 2015-05-20 湖南中烟工业有限责任公司 一种β-环糊精-g-乳酸共聚物的应用
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
EP3267875A4 (en) 2015-03-12 2018-12-05 Chrono Therapeutics Inc. Craving input and support system
US20170172995A1 (en) * 2015-09-08 2017-06-22 Venkateswara Rao Repaka Pharmaceutical compositions of Nicotine and process for preparation thereof
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
EP3906916A1 (en) * 2017-12-08 2021-11-10 Fertin Pharma A/S Nicotine tablet
CA3101966A1 (en) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Drug delivery methods and systems
WO2020012009A1 (en) 2018-07-13 2020-01-16 Mcneil Ab Chewing gum comprising nicotine
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
CA3167882A1 (en) 2020-01-15 2021-07-22 Mcneil Ab Lozenge
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
WO2023067087A1 (en) * 2021-10-21 2023-04-27 Mcneil Ab Nicotine chewing gum

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3877468A (en) * 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US5783207A (en) * 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
GB8615676D0 (en) * 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US5004651A (en) * 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
US5167242A (en) * 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
FI943206A7 (fi) * 1992-01-06 1994-07-05 Du Pont Tablettiformulaatio, jossa on sisäinen kuivausaine
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US5889028A (en) * 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
US5810081A (en) * 1997-02-24 1998-09-22 Cobb; Delwin E. Wear structure for bore hole separation device
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
EP1501546B1 (de) * 2002-05-03 2012-10-10 Hexal AG Stabile pharmazeutische formulierung für eine kombination aus einem statin mit einem ace-hemmer
WO2003101431A1 (en) * 2002-06-04 2003-12-11 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
US20030049307A1 (en) * 2002-08-15 2003-03-13 Gyurik Robert J. Pharmaceutical composition
US20040052851A1 (en) * 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form

Also Published As

Publication number Publication date
RU2448707C2 (ru) 2012-04-27
AU2007250589A1 (en) 2007-11-22
NZ572758A (en) 2011-01-28
AR060931A1 (es) 2008-07-23
JP2009537514A (ja) 2009-10-29
TW200810755A (en) 2008-03-01
MX2008014726A (es) 2009-02-04
AU2007250589B2 (en) 2011-04-14
EP2023928A4 (en) 2012-08-29
CN101472591A (zh) 2009-07-01
WO2007133141A1 (en) 2007-11-22
CA2652500C (en) 2014-07-29
EP2023928A1 (en) 2009-02-18
ZA200810618B (en) 2010-02-24
KR20090024161A (ko) 2009-03-06
RU2008149508A (ru) 2010-06-27
BRPI0712068A2 (pt) 2012-01-17
KR101414063B1 (ko) 2014-07-18
CA2652500A1 (en) 2007-11-22
JP5254213B2 (ja) 2013-08-07
US20070269492A1 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
MX2009012484A (es) Formulacion de nicotina oral recubierta regulada con aminoacido.
NO20084992L (no) Farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel
AR060931A1 (es) Producto farmaceutico recubierto para la administracion intraoral de nicotina y su uso y elaboracion
NO20084752L (no) Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse
WO2009141321A3 (en) Tablettable chewing gums comprising nicotine and a buffering agent
BR112021018054A2 (pt) Composição de tabaco, método para produção da composição de tabaco, uso de uma composição de tabaco, artigo para uso em um sistema de fornecimento de aerossol e sistema
UA94129C2 (ru) Соединения для ингибирования митоза
NO20084541L (no) Fuktig snussammensetning som ikke inneholder tobakk og fremgangsmate for fremstilling derav
WO2008069970A3 (en) Nicotine formulations, kits and systems and methods for their use
PE20071250A1 (es) Formulaciones farmaceuticas que comprenden pleconaril
EA201071040A1 (ru) Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40
AR078417A1 (es) Composiciones de pelicula sublingual y bucal
MY164646A (en) Nicotine lozenge compositions
UA106098C2 (uk) Аерозольна композиція для хозл
MX2008010172A (es) Suministro pulmonar de inhibidor de proteinasa alafa-i.
AU2009215514A9 (en) Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
WO2014093127A3 (en) Method of administering nicotine, thc, tobacco, cannabidiol or base alkaloid and absorption conditioning unit
MX2009011862A (es) Composiciones farmaceuticas de administracion oronasofaringea de agonistas de la dopamina para la prevencion/alivio y/o tratamiento del desorden de miembros inquietos.
EA201170520A1 (ru) Ингибитор p38 mapk-киназы
MX2007004495A (es) Composiciones y procedimientos para la administracion intranasal, bucal, sublingual y pulmonar de vareniclina.
MX2010003923A (es) Formulacion farmaceutica de valsartan.
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
CL2008001301A1 (es) Compuestos derivados de heterociclos de nitrogeno; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una condicion inflamatoria o alergica, tal como una enfermedad inflamatoria u obstructiva de las vias respiratorias mediada por el bloqueo del canal de sodio epitelial.
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
BRPI0922796A2 (pt) Comprimido farmacêutico para administração por via oral e método de fabricação do mesmo

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application